164 related articles for article (PubMed ID: 38274259)
1. Intracellular Delivery of Stabilized Peptide Blocking MTDH-SND1 Interaction for Breast Cancer Suppression.
Chen H; Zhan M; Zhang Y; Liu J; Wang R; An Y; Gao Z; Jiang L; Xing Y; Kang Y; Li Z; Yin F
JACS Au; 2024 Jan; 4(1):139-149. PubMed ID: 38274259
[TBL] [Abstract][Full Text] [Related]
2. Structure-Based Design, Optimization, and Evaluation of Potent Stabilized Peptide Inhibitors Disrupting MTDH and SND1 Interaction.
Chen H; Zhan M; Liu J; Liu Z; Shen M; Yang F; Kang Y; Yin F; Li Z
J Med Chem; 2022 Sep; 65(18):12188-12199. PubMed ID: 36044768
[TBL] [Abstract][Full Text] [Related]
3. Disruption of SND1-MTDH Interaction by a High Affinity Peptide Results in SND1 Degradation and Cytotoxicity to Breast Cancer Cells
Li P; He Y; Chen T; Choy KY; Chow TS; Wong ILK; Yang X; Sun W; Su X; Chan TH; Chow LMC
Mol Cancer Ther; 2021 Jan; 20(1):76-84. PubMed ID: 33268570
[TBL] [Abstract][Full Text] [Related]
4. Small-molecule inhibitors that disrupt the MTDH-SND1 complex suppress breast cancer progression and metastasis.
Shen M; Wei Y; Kim H; Wan L; Jiang YZ; Hang X; Raba M; Remiszewski S; Rowicki M; Wu CG; Wu S; Zhang L; Lu X; Yuan M; Smith HA; Zheng A; Bertino J; Jin JF; Xing Y; Shao ZM; Kang Y
Nat Cancer; 2022 Jan; 3(1):43-59. PubMed ID: 35121987
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into the tumor-promoting function of the MTDH-SND1 complex.
Guo F; Wan L; Zheng A; Stanevich V; Wei Y; Satyshur KA; Shen M; Lee W; Kang Y; Xing Y
Cell Rep; 2014 Sep; 8(6):1704-1713. PubMed ID: 25242325
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological disruption of the MTDH-SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer.
Shen M; Smith HA; Wei Y; Jiang YZ; Zhao S; Wang N; Rowicki M; Tang Y; Hang X; Wu S; Wan L; Shao ZM; Kang Y
Nat Cancer; 2022 Jan; 3(1):60-74. PubMed ID: 35121988
[TBL] [Abstract][Full Text] [Related]
7. MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition.
He A; He S; Huang C; Chen Z; Wu Y; Gong Y; Li X; Zhou L
Aging (Albany NY); 2020 Jan; 12(2):1465-1487. PubMed ID: 31978894
[TBL] [Abstract][Full Text] [Related]
8. Identification of Small Inhibitors for Human Metadherin, an Oncoprotein, through
Khattak AA; Ahmad A; Khattak HA; Irshad Khan MZ
Curr Comput Aided Drug Des; 2023; 19(4):278-287. PubMed ID: 36627784
[TBL] [Abstract][Full Text] [Related]
9. Correction to "Structure-Based Design, Optimization, and Evaluation of Potent Stabilized Peptide Inhibitors Disrupting MTDH and SND1 Interaction".
Chen H; Zhan M; Liu J; Liu Z; Shen M; Yang F; Kang Y; Yin F; Li Z
J Med Chem; 2023 Jun; 66(11):7668. PubMed ID: 37227932
[No Abstract] [Full Text] [Related]
10. Molecular Dynamics Simulation-Driven Focused Virtual Screening and Experimental Validation of Inhibitors for MTDH-SND1 Protein-Protein Interaction.
Xu Y; Guo X; Yan D; Dang X; Guo L; Jia T; Wang Q
J Chem Inf Model; 2023 Jun; 63(11):3614-3627. PubMed ID: 37226724
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of Metadherin-SND1 interaction in colon cancer.
Wang N; Du X; Zang L; Song N; Yang T; Dong R; Wu T; He X; Lu J
Mol Biol Rep; 2012 Dec; 39(12):10497-504. PubMed ID: 23065261
[TBL] [Abstract][Full Text] [Related]
12. MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors.
Wan L; Lu X; Yuan S; Wei Y; Guo F; Shen M; Yuan M; Chakrabarti R; Hua Y; Smith HA; Blanco MA; Chekmareva M; Wu H; Bronson RT; Haffty BG; Xing Y; Kang Y
Cancer Cell; 2014 Jul; 26(1):92-105. PubMed ID: 24981741
[TBL] [Abstract][Full Text] [Related]
13. Correlated overexpression of metadherin and SND1 in glioma cells.
Tong L; Wang C; Hu X; Pang B; Yang Z; He Z; He M; Wei L; Chu M
Biol Chem; 2016 Jan; 397(1):57-65. PubMed ID: 26351803
[TBL] [Abstract][Full Text] [Related]
14. Exploring binding modes of the selected inhibitors to SND1 by all-atom molecular dynamics simulations.
Pang P; Liu S; Hao X; Tian Y; Gong S; Miao D; Zhang Y
J Biomol Struct Dyn; 2023 Jun; ():1-15. PubMed ID: 37345536
[TBL] [Abstract][Full Text] [Related]
15. Identification of staphylococcal nuclease domain-containing 1 (SND1) as a Metadherin-interacting protein with metastasis-promoting functions.
Blanco MA; Alečković M; Hua Y; Li T; Wei Y; Xu Z; Cristea IM; Kang Y
J Biol Chem; 2011 Jun; 286(22):19982-92. PubMed ID: 21478147
[TBL] [Abstract][Full Text] [Related]
16. Efficient and tumor-specific knockdown of MTDH gene attenuates paclitaxel resistance of breast cancer cells both in vivo and in vitro.
Yang L; Tian Y; Leong WS; Song H; Yang W; Wang M; Wang X; Kong J; Shan B; Song Z
Breast Cancer Res; 2018 Sep; 20(1):113. PubMed ID: 30227879
[TBL] [Abstract][Full Text] [Related]
17. The chromatin architectural regulator SND1 mediates metastasis in triple-negative breast cancer by promoting CDH1 gene methylation.
Zhang H; Gao M; Zhao W; Yu L
Breast Cancer Res; 2023 Oct; 25(1):129. PubMed ID: 37885030
[TBL] [Abstract][Full Text] [Related]
18. SND1 Acts Downstream of TGFβ1 and Upstream of Smurf1 to Promote Breast Cancer Metastasis.
Yu L; Liu X; Cui K; Di Y; Xin L; Sun X; Zhang W; Yang X; Wei M; Yao Z; Yang J
Cancer Res; 2015 Apr; 75(7):1275-86. PubMed ID: 25596283
[TBL] [Abstract][Full Text] [Related]
19. SND1 acts as a novel gene transcription activator recognizing the conserved Motif domains of Smad promoters, inducing TGFβ1 response and breast cancer metastasis.
Yu L; Di Y; Xin L; Ren Y; Liu X; Sun X; Zhang W; Yao Z; Yang J
Oncogene; 2017 Jul; 36(27):3903-3914. PubMed ID: 28263968
[TBL] [Abstract][Full Text] [Related]
20. Role of metadherin in estrogen-regulated gene expression.
Li Y; Gonzalez Bosquet J; Yang S; Thiel KW; Zhang Y; Liu H; Leslie KK; Meng X
Int J Mol Med; 2017 Aug; 40(2):303-310. PubMed ID: 28627585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
